Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPAG11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TOP1P2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DHRS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TMEM74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLIPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATAD2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERVFRD-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSCAN12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC11A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KATNBL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLAC8L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPAN32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC26A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on